ADC Therapeutics SA
ADCT
$3.70
-$0.26-6.57%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.64% | 21.31% | 20.92% | 34.07% | 34.25% |
| Total Depreciation and Amortization | -42.74% | -23.24% | -5.19% | -4.52% | 0.28% |
| Total Amortization of Deferred Charges | 101.77% | -52.76% | -67.43% | -78.06% | -70.09% |
| Total Other Non-Cash Items | -11.15% | -51.40% | -52.64% | -64.48% | -63.27% |
| Change in Net Operating Assets | -762.70% | -723.79% | 152.36% | -1,197.15% | -91.36% |
| Cash from Operations | -14.00% | 1.28% | 12.34% | 7.68% | -4.34% |
| Capital Expenditure | 69.55% | 67.93% | 63.20% | 78.03% | 73.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 145.56% | 67.93% | 63.20% | 78.03% | 73.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 54.05% | -4.75% | -5.09% | 13,944.11% | 12,703.10% |
| Repurchase of Common Stock | 16.16% | -83.07% | -229,100.00% | -204,100.00% | -204,100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 55.53% | -5.54% | -7.39% | 31.38% | 31.38% |
| Foreign Exchange rate Adjustments | 467.47% | -103.16% | 8,966.67% | 132.69% | -145.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.76% | -9.41% | 24.97% | 48.09% | 42.04% |